Differences in Patient-Reported Experiences of Care by Race and Acculturation Status by Hasnain, Memoona, Schwartz, Alan, Girotti, Jorge, Bixby, Angela, Rivera, Luis

Get full text

Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants by Di Cesare, Mariachiara, Bentham, James, Stevens, Gretchen A, Bjertness, Espen, Bjertness, Marius Bergsmark, Ekelund, Ulf, Graff-Iversen, Sidsel, Kolle, Elin, Krokstad, Steinar, Steene-Johannessen, Jostein

Get full text

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymp... by Chanan-Khan, Asher, Prof, Cramer, Paula, MD, Demirkan, Fatih, MD, Fraser, Graeme, MD, Silva, Rodrigo Santucci, MD, Grosicki, Sebastian, Prof, Pristupa, Aleksander, MD, Janssens, Ann, MD, Mayer, Jiri, Prof, Bartlett, Nancy L, Prof, Dilhuydy, Marie-Sarah, MD, Pylypenko, Halyna, MD, Loscertales, Javier, MD, Avigdor, Abraham, MD, Rule, Simon, Prof, Villa, Diego, MD, Samoilova, Olga, MD, Panagiotidis, Panagiots, Prof, Goy, Andre, MD, Mato, Anthony, MD, Pavlovsky, Miguel A, MD, Karlsson, Claes, MD, Mahler, Michelle, MD, Salman, Mariya, PhD, Sun, Steven, PhD, Phelps, Charles, MS, Balasubramanian, Sriram, PhD, Howes, Angela, PhD, Hallek, Michael, MD

Get full text

Initial Results from a Biomarker-Directed Phase 2 Trial of SY-1425, a Potent and Selective RARα Agonist, in Combination with Azacitidine in Relapsed/Refractory Acute Myeloid Leukem... by Stein, Eytan M., De Botton, Stephane, Cluzeau, Thomas, Pigneux, Arnaud, Liesveld, Jane L., Cook, Rachel J., Rousselot, Philippe, Rizzieri, David A, Braun, Thorsten, Bixby, Dale L., Roboz, Gail J., Lebon, Delphine, Heiblig, Mael, Kelly, Michael J., Volkert, Angela, Zhou, Li, Kang-Fortner, Qing, Roth, David A., Peterlin, Pierre

Get full text

Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML by de Botton, Stéphane, Cluzeau, Thomas, Vigil, Carlos, Cook, Rachel J., Rousselot, Philippe, Rizzieri, David A., Liesveld, Jane L., Fenaux, Pierre, Braun, Thorsten, Banos, Anne, Jurcic, Joseph G., Sekeres, Mikkael A., Savona, Michael R., Roboz, Gail J., Bixby, Dale, Madigan, Kate, Volkert, Angela, Stephens, Kristin, Kang-Fortner, Qing, Baker, Kristen, Paul, Sofia, McKeown, Michael, Carulli, John, Eaton, Matthew, Hodgson, Graeme, Fiore, Christopher, Kelly, Michael J., Roth, David A., Stein, Eytan M.

Get full text

Early Results from a Biomarker-Directed Phase 2 Trial of Sy-1425 in Combination with Azacitidine or Daratumumab in Non-APL Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome... by Cook, Rachel J., Moyo, Tamara, Liesveld, Jane L., Rizzieri, David A., Stein, Eytan M., De Botton, Stephane, Roboz, Gail J., Sekeres, Mikkael A., Jurcic, Joseph G., Raza, Azra, Redner, Robert L., Bixby, Dale L., Cortes, Jorge E., Stephens, Kristin, Volkert, Angela, Kang, Qing, Di Tomaso, Emmanuelle, Roth, David A., Vigil, Carlos E

Get full text

Early Results from a Biomarker-Directed Phase 2 Trial of Sy-1425 in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Demonstrate DHRS3 Induction and Myeloid Differen... by Jurcic, Joseph G., Raza, Azra, Vlad, George, Stein, Eytan M., Roshal, Mikhail, Bixby, Dale L., Boyer, Daniel F., Vigil, Carlos Enrique, Syrbu, Sergei, Sekeres, Mikkael A., Rogers, Heesun J., Rizzieri, David A., Lagoo, Anand Shreeram, Roboz, Gail J., Redner, Robert L., Steensma, David P., Cook, Rachel J., Moyo, Tamara, McKeown, Michael, Waters, Nigel J., Stephens, Kristin, Volkert, Angela, Di Tomaso, Emmanuelle, Roth, David A., Cortes, Jorge E.

Get full text